The present invention relates to modified vesicular stomatitis virus glycoprotein (VSV-G) comprising at least one peptide, preferably an antigen or fragment thereof, nucleic acid sequence coding therefor, and vectors containing said nucleic acid sequence. The present invention also relates to vaccines and methods for the treatment of a disease or condition, in particular a cancer or an infectious disease.
